About First Trust Nasdaq Pharmaceuticals ETF (FTXH)

The First Trust Nasdaq Pharmaceuticals ETF (FTXH) is an exchange-traded fund that seeks to track the performance of the Nasdaq US Smart Pharmaceuticals Index. This index is designed to track the performance of US companies engaged in the pharmaceuticals sector. FTXH provides investors with exposure to a diversified portfolio of pharmaceutical companies, including both large and small-cap stocks. By investing in FTXH, investors can gain access to the potential growth and returns of the pharmaceutical industry.

FTXH has a market capitalization of [market cap]. The ETF has a PEG ratio of [PEG Ratio], which is a valuation metric that compares the price-to-earnings ratio of a company to its expected growth rate. A PEG ratio below 1 is generally considered to be undervalued, while a ratio above 1 may indicate an overvalued stock. FTXH's PEG ratio suggests that the ETF may be undervalued relative to its expected growth.